NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) is harnessing powerful human biology to radically reshape the treatment of some of today's toughest diseases.

South San Francisco, CA
Joined December 2014
Jeff Jonker @NGMBio talks w/ @ScripMikeWard about #NASH and drug candidate NGM282 at #JPM18 #BTS18
1
4
Weight-control mechanism detailed by @NGMBio researchers, now working with @Merck on weight drugs: ow.ly/DtD330fzKov
3
4
One of the nicest guys in our industry! Nice highlight @rleuty_biotech @Jeff_Jonker bizjournals.com/sanfrancisco… via @SFBusinessTimes
JCI - Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis jci.org/articles/view/93465#…
2
2
#ilc2017 poster tours were a huge draw on Thursday don't miss today or Saturday goo.gl/iJ6YiO
NGM Bio retweeted
$MRK enters into 5yr research & development collaboration on novel biologics with @NGMBio. Learn more at: bit.ly/1EHUqFj
3
3